Article
No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Cancer biology & therapy - 1 Nov 2010
Yuan Peng, Liu Li, Wu Chen, Zhong Rong, Yu Dianke, Wu Jing, Xu Yihua, Nie Shaofa, Miao Xiaoping, Sun Yan, Xu Binghe, Lin Dongxin
Abstract excerpt
PURPOSE: genetic polymorphisms in DNA repair genes are thought to represent important determinants of platinum drug efficacy. The current study investigated whether single nucleotide polymorphisms (SNPs) in the X-ray repair cross complementing protein 1 (XRCC1) gene are associated with survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. EXPERIMENTAL DESIGN: a total of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
